SLC25A21 and central nervous system cancer: As there is some evidence suggesting that UPP1 and SMOC1 are markers for glioma, our finding of KCNA4 and SLC25A21 add to the previously identified gene list to fortify patient outcome prediction and guide future investigations on the impact of these genes and their pathways involved in glioma progression.